Estrogen Alters the Splicing of Type 1 Corticotropin-Releasing Hormone Receptor in Breast Cancer Cells

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Science Signaling

• Publication date

  2013-07-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1126/scisignal.2003926PMID 23821771
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• GSK-3β: A Bifunctional Role in Cell Death Pathways

  2012cited by this paper
• Role of corticotropin-releasing hormone family peptides in androgen receptor and vitamin D receptor expression and translocation in human breast cancer MCF-7 cells.

  2012cited by this paper
• Minireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers.

  2012cited by this paper
• The wnt/β‐catenin signaling pathway: A potential therapeutic target in the treatment of triple negative breast cancer

  2012cited by this paper
• Stress and breast cancer: from epidemiology to molecular biology

  2011cited by this paper
• Retrograde transport of the transmembrane estrogen receptor, G-protein-coupled-receptor-30 (GPR30/GPER) from the plasma membrane towards the nucleus.

  2011cited by this paper
• Tumorigenicity of MCF-7 human breast cancer cells lacking the p38α mitogen-activated protein kinase.

  2011cited by this paper
• Corticorelin acetate, a synthetic corticotropin-releasing factor with preclinical antitumor activity, alone and with bevacizumab, against human solid tumor models

  2011cited by this paper
• Heat shock proteins in breast cancer progression–A suitable case for treatment?

  2010cited by this paper
• GSK3: a multifaceted kinase in Wnt signaling.

  2010cited by this paper
• The impact of stress on tumor growth: peripheral CRF mediates tumor-promoting effects of stress

  2010cited by this paper
• GNCPro: navigate human genes and relationships through net-walking.

  2010cited by this paper
• Distinct distribution of corticotropin releasing factor receptors in human breast cancer.

  2010cited by this paper
• Apoptosis of human melanoma cells induced by inhibition of B-RAFV600E involves preferential splicing of bimS

  2010cited by this paper
• Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged.

  2010cited by this paper
• Identification of a novel corticotropin-releasing hormone type 1beta-like receptor variant lacking Exon 13 in human pregnant myometrium regulated by estradiol-17beta and progesterone.

  2010cited by this paper
• Nuclear β-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells

  2010cited by this paper
• Quantitative Nanoproteomics for Protein Complexes (QNanoPX) Related to Estrogen Transcriptional Action*

  2009cited by this paper
• Focus on the splicing of secretin GPCRs transmembrane-domain 7.

  2009cited by this paper
• Corticotropin Releasing Factor promotes breast cancer cell motility and invasiveness

  2009cited by this paper
• Id-1 activates Akt-mediated Wnt signaling and p27Kip1 phosphorylation through PTEN inhibition

  2009cited by this paper
• Identification of estrogen‐responsive proteins in MCF‐7 human breast cancer cells using label‐free quantitative proteomics

  2008cited by this paper
• 2-Methoxyestradiol and multidrug resistance: can 2-methoxyestradiol chemosensitize resistant breast cancer cells?

  2008cited by this paper
• Wnt and beyond Wnt: multiple mechanisms control the transcriptional property of beta-catenin.

  2008cited by this paper
• Structural determinants critical for localization and signaling within the seventh transmembrane domain of the type 1 corticotropin releasing hormone receptor: lessons from the receptor variant R1d.

  2008cited by this paper
• Insights into the connection between cancer and alternative splicing.

  2008cited by this paper
• Neuroendocrine influences on cancer biology.

  2008cited by this paper
• Alternative Splicing and Tumor Progression

  2008cited by this paper
• Urocortin2 inhibits tumor growth via effects on vascularization and cell proliferation

  2008cited by this paper
• Phosphorylation by p38 MAPK as an Alternative Pathway for GSK3β Inactivation

  2008cited by this paper
• Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation

  2007cited by this paper
• Phosphorylation of Ser78 of Hsp27 correlated with HER-2/neu status and lymph node positivity in breast cancer

  2007cited by this paper
• Evidence that corticotropin-releasing hormone inhibits cell growth of human breast cancer cells via the activation of CRH-R1 receptor subtype.

  2007cited by this paper
• Alternative splicing: an emerging topic in molecular and clinical oncology.

  2007cited by this paper
• Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation

  2007cited by this paper
• The early response to DNA damage can lead to activation of alternative splicing activity resulting in CD44 splice pattern changes.

  2007cited by this paper
• The onset of labor alters corticotropin-releasing hormone type 1 receptor variant expression in human myometrium: putative role of interleukin-1beta.

  2007cited by this paper
• CRH functions as a growth factor/cytokine in the skin

  2006cited by this paper
• A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells.

  2006cited by this paper
• Identification of signaling molecules mediating corticotropin-releasing hormone-R1alpha-mitogen-activated protein kinase (MAPK) interactions: the critical role of phosphatidylinositol 3-kinase in regulating ERK1/2 but not p38 MAPK activation.

  2006cited by this paper
• A Wnt–Axin2–GSK3β cascade regulates Snail1 activity in breast cancer cells

  2006cited by this paper
• The influence of bio-behavioural factors on tumour biology: pathways and mechanisms

  2006cited by this paper
• Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach.

  2006cited by this paper
• Tumor suppressor genes in breast cancer: the gatekeepers and the caretakers.

  2005cited by this paper
• Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity.

  2005cited by this paper
• A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell Signaling

  2005cited by this paper
• Application of Real-Time Cell Electronic Sensing (RT-CES) Technology to Cell-Based Assays

  2004cited by this paper
• Akt/Protein Kinase B Signaling Inhibitor-2, a Selective Small Molecule Inhibitor of Akt Signaling with Antitumor Activity in Cancer Cells Overexpressing Akt

  2004cited by this paper
• Promoter analysis of human corticotropin-releasing factor (CRF) type 1 receptor and regulation by CRF and urocortin.

  2004influential reference
• Human Chorionic Gonadotropin Decreases Proliferation and Invasion of Breast Cancer MCF-7 Cells by Inhibiting NF-κB and AP-1 Activation*

  2004cited by this paper
• Stress, depression, the immune system, and cancer.

  2004cited by this paper
• ESEfinder: a web resource to identify exonic splicing enhancers

  2003cited by this paper
• Expression of CRF1 and CRF2 receptors in human cancers.

  2003cited by this paper
• CRH inhibits cell growth of human endometrial adenocarcinoma cells via CRH-receptor 1-mediated activation of cAMP-PKA pathway.

  2002cited by this paper
• Corticotropin releasing factor receptor type 1: molecular cloning and investigation of alternative splicing in the hamster skin.

  2002cited by this paper
• Alternative splicing of CRH‐R1 receptors in human and mouse skin: identification of new variants and their differential expression

  2001cited by this paper
• Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors.

  1998cited by this paper
• Differential screening and suppression subtractive hybridization identified genes differentially expressed in an estrogen receptor-positive breast carcinoma cell line.

  1998cited by this paper
• Anti-neoplastic properties of human corticotropin releasing factor: involvement of the nitric oxide pathway.

  1998cited by this paper
• Gatekeepers and caretakers

  1997cited by this paper
• Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

  1995cited by this paper
• Corticotropin-releasing hormone, luteinizing hormone-releasing hormone, growth hormone-releasing hormone, and somatostatin-like immunoreactivities in biopsies from breast cancer patients

  1990cited by this paper
• Estradiol induced proteins in the MCF7 human breast cancer cell line.

  1979cited by this paper

• Stress regulatory hormones and cancer: the contribution of epinephrine and cancer therapeutic value of beta blockers

  2025cites this paper
• The Involvement of the Peptidergic Systems in Breast Cancer Development

  2025cites this paper
• Dysregulation of splicing variants and spliceosome components in breast cancer.

  2022cites this paper
• Role of CRF and the hypothalamic‐pituitary‐adrenal axis in stroke: revisiting temporal considerations and targeting a new generation of therapeutics

  2022cites this paper
• Sex-Related Predisposition to Post-Traumatic Stress Disorder Development—The Role of Neuropeptides

  2021cites this paper
• Targeting Splicing Factor SRSF6 for Cancer Therapy

  2021cites this paper
• Splicing Factor Transcript Abundance in Saliva as a Diagnostic Tool for Breast Cancer

  2020cites this paper
• Corticotropin Releasing Factor Receptors in breast cancer: Expression and activity in hormone-dependent growth in vitro.

  2020cites this paper
• Insights into Gene Expression and the Influence of Regulatory Mechanisms within Meningioma - A Bioinformatic Approach

  2020cites this paper
• Identification and Validation of Stage-Associated PBMC Biomarkers in Breast Cancer Using MS-Based Proteomics

  2020cites this paper
• The Role of RNA Splicing Factors in Cancer: Regulation of Viral and Human Gene Expression in Human Papillomavirus-Related Cervical Cancer

  2020cites this paper
• Overexpression of corticotropin-releasing factor in the nucleus accumbens enhances the reinforcing effects of nicotine in intact female versus male and ovariectomized female rats

  2019cites this paper
• FGFR1β is a driver isoform of FGFR1 alternative splicing in breast cancer cells

  2019cites this paper
• Alternative Splicing (AS) and Epithelial-to-Mesenchymal Transition (EMT) programming in cellular model of breast cancer

  2018influential citation
• Corticotropin-releasing factor 1 receptor haplotype and cognitive features of major depression

  2018cites this paper
• Androgen-dependent alternative mRNA isoform expression in prostate cancer cells

  2018cites this paper
• The impact of the RBM4-initiated splicing cascade on modulating the carcinogenic signature of colorectal cancer cells

  2017cites this paper
• CRH Receptor Signalling: Potential Roles in Pathophysiology.

  2017cites this paper
• Tumour promoting HER2 splice variant Δ16HER2: Regulation and implication in breast cancer

  2016cites this paper
• Uncoupling of circadian and other maternal cues in decidualizing endometrial cells

  2015cites this paper
• Estrogen receptor beta impacts hormone-induced alternative mRNA splicing in breast cancer cells

  2015cites this paper
• The clock protein period 2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells

  2015cites this paper
• The RNAissance family: SR proteins as multifaceted regulators of gene expression

  2015cites this paper
• Deregulation of splicing factors and breast cancer development.

  2015influential citation
• CRH-R splicing in estrogen-sensitive breast cancer

  2014cites this paper
• 2013: Signaling Breakthroughs of the Year

  2014cites this paper
• IOLOGY 2013 : Signaling Breakthroughs of the Year

  2014cites this paper